Product fact sheet

MitoPRO 750X Technical Profile

Name: MitoPRO 750X
Brand: Mito Red Light

MitoPRO 750X specifications list a 23 × 10 × 3 inch panel, six nominal wavelength peaks, 150 LED lenses / 300 chips, 225 W power and optional 10 Hz NIR pulsing.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →

Desk researchedFacts checked 2026-08-11

A six-wavelength mid-size MitoPRO X panel documented in the January 2026 family manual, with app/remote controls and a larger footprint than the 300X.

Fit signals

mid-size panel specification comparisons, buyers who want the current MitoPRO X manual as a primary source

Potential constraints

buyers requiring common-protocol independent output measurements, anyone treating wavelength count as proof of efficacy

Key tradeoff: The primary manual is detailed, but normalized optical-output evidence remains manufacturer-supplied.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

What the primary manual establishes

The January 2026 MitoPRO X manual lists the 750X at 23 × 10 × 3 inches and 15 lb gross, with six nominal peaks—590, 630, 660, 810, 830 and 850 nm—each stated with a ±10 nm tolerance. The family manual also documents IP21 ingress protection, Class II electrical-protection language, mode-specific timers and optional 10 Hz near-infrared pulsing.

The current product page separately publishes 150 LED lenses / 300 chips and 225 W power. Those remain manufacturer-published specifications unless independently reproduced.

Evidence boundary

No independent measurements of irradiance, spectral output, electrical consumption, heat, fan noise or treatment-area uniformity are included for this model. Manufacturer performance figures should remain labeled as manufacturer evidence until a compatible third-party protocol exists.

Comparison points

Compare physical footprint, wavelength set, LED architecture, timer/pulse behavior, setup method and source quality. The six wavelength peaks and 10 Hz option describe hardware capability; they do not establish a condition-specific treatment advantage by themselves.

Technical specifications

Published specs and what they mean

Physical

Dimensions: 23 × 10 × 3 in
Weight: 15 lb gross

Optical

Wavelengths: 590 / 630 / 660 / 810 / 830 / 850 nm (±10 nm)
LED architecture: 150 lenses / 300 chips

Electrical

Published power: 225 W

Controls

Timer ranges: M1/M2 1–20 min; M3 1–10 min
Pulse mode: M1/M3 optional NIR 10 Hz; M2 no pulse

Environment

Ingress protection: IP21

What the current record does not establish

No independent common-protocol irradiance measurement is normalized for this model.
Manufacturer product-page dimensions and manual dimensions should be treated as source-specific rather than silently reconciled.
No Homeapotherapy hands-on electrical, thermal or acoustic measurements exist.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

No comparable independent average irradiance is normalized

This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.

What this calculation still cannot tell you

whether this is an effective dose for any condition;
how irradiance changes at a different distance or across curved anatomy;
how much energy reaches tissue below the surface;
whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 590 / 630 / 660 / 810 / 830 / 850 nm (±10 nm).

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.

Do not infer from wavelength overlap

that this device is clinically proven for the linked condition;
that more wavelengths are better;
that the highest published irradiance is the best dose;
that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Follow the current user manual, including eye-protection and photosensitivity guidance. Hardware specifications do not establish clinical effectiveness for a particular condition.

The manual warns against direct eye contact with the LEDs and provides protective eyewear guidance.
Photosensitizing medicines and health conditions warrant clinician review before use.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

No merchant destination is currently tracked for this product.

Source trail

Primary documents and supporting evidence

MitoPRO X Red Light Therapy PanelMito Red Light · Manufacturer · retrieved 2026-08-10
MitoPRO X User Manual — January 2026Mito Red Light · Manufacturer manual · PDF · retrieved 2026-08-10
Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10

Comparable products